Lumos Diagnostics Holdings Limited
LDXHF
$0.015
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.50% | 23.70% | 4.22% | 65.29% | 78.59% |
| Total Depreciation and Amortization | -20.82% | -31.34% | -39.58% | -33.18% | -27.24% |
| Total Amortization of Deferred Charges | 40.60% | 40.60% | 40.60% | 69.51% | 138.42% |
| Total Other Non-Cash Items | -587.11% | -2,724.19% | 227.54% | -93.46% | -96.96% |
| Change in Net Operating Assets | 237.53% | 237.53% | 237.53% | 121.01% | -27.18% |
| Cash from Operations | 93.81% | 102.29% | 109.82% | 65.40% | 30.67% |
| Capital Expenditure | 47.83% | 53.33% | 58.40% | 80.54% | 84.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -146.67% | -84.44% | -53.33% | 84.20% | 95.79% |
| Cash from Investing | -102.24% | -102.26% | -102.28% | 31.57% | 497.80% |
| Total Debt Issued | -- | -- | -- | 0.00% | -- |
| Total Debt Repaid | 59.65% | 22.17% | -29.52% | -37.84% | -46.69% |
| Issuance of Common Stock | 26.40% | 126.40% | -- | -57.81% | -78.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 60.99% | 69.40% | 100.00% | 97.18% | 97.16% |
| Cash from Financing | 4.98% | 39.67% | 303.37% | 6.13% | -23.70% |
| Foreign Exchange rate Adjustments | -185.23% | -1.39% | 95.07% | 94.66% | 94.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 596.81% | 274.42% | 169.80% | 127.72% | 106.16% |
